GLP-1 receptor agonists, the drug class that includes semaglutide (sold as Ozempic and Wegovy), appear to reduce cravings, lower overdose risk and decrease substance use disorder diagnoses in real-world studies
Observational data cant prove causation, but the consistency across substances and outcomes provides a strong rationale for clinical trials
Changes in lipid metabolism showed elevated monostearin from lipid breakdown, reduced heptanoic acid as energy substrate, and increased malonate supporting membrane integrity
Kappa opioid receptors on dopaminergic neurons are necessary for Kappa-mediated place aversion
We know that some of the manufacturers that have current TrumpRx agreements do produce psychotropic medications, but we dont currently have a full list of medications that will be available through TrumpRx, nor do we know exactly how many manufacturers will participate